Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Endophina ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   13.3% 9.1% 4.1% 7.8% 8.2% 8.9% 16.1% 15.9%   Credit score (0-100)   18 28 49 30 29 27 11 12   Credit rating   BB BB BBB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   105 198 452 273 1,189 740 0.0 0.0   EBITDA   65.3 151 239 -122 5.6 -214 0.0 0.0   EBIT   53.4 139 227 -134 -1.3 -214 0.0 0.0   Pre-tax profit (PTP)   45.2 136.6 227.4 -136.1 -7.6 -221.2 0.0 0.0   Net earnings   35.2 106.5 177.3 -106.1 -6.5 -221.2 0.0 0.0   Pre-tax profit without non-rec. items   45.2 137 227 -136 -7.6 -221 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   42.4 30.6 18.7 6.9 0.0 0.0 0.0 0.0   Shareholders equity total   25.3 132 259 3.0 -2.1 -120 -170 -170   Interest-bearing liabilities   0.0 0.0 0.0 150 0.0 455 170 170   Balance sheet total (assets)   201 286 444 245 270 348 0.0 0.0   Net Debt   -68.7 -90.2 -269 52.0 -83.3 272 170 170     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   105 198 452 273 1,189 740 0.0 0.0   Gross profit growth   0.0% 89.0% 128.6% -39.6% 335.4% -37.8% -100.0% 0.0%   Employees   1 1 1 1 3 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 200.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   201 286 444 245 270 348 0 0   Balance sheet change%   16.8% 42.4% 55.3% -45.0% 10.3% 29.1% -100.0% 0.0%   Added value   65.3 151.0 239.2 -122.2 10.5 -213.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -24 -24 -24 -24 -14 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.1% 70.3% 50.3% -49.1% -0.1% -28.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.1% 57.7% 62.6% -38.6% -0.5% -57.7% 0.0% 0.0%   ROI %   425.2% 177.5% 116.7% -64.6% -1.8% -93.8% 0.0% 0.0%   ROE %   35.7% 135.6% 90.7% -81.0% -4.7% -71.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   12.6% 46.1% 58.3% 1.2% -0.8% -25.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -105.3% -59.8% -112.4% -42.6% -1,490.2% -127.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 5,013.1% 0.0% -380.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 3.9% 8.2% 3.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 1.3 2.0 0.7 1.7 3.0 0.0 0.0   Current Ratio   0.6 1.3 2.0 0.7 1.7 3.0 0.0 0.0   Cash and cash equivalent   68.7 90.2 268.8 98.2 83.3 182.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -74.7 43.7 181.6 -62.7 84.4 194.6 -84.8 -84.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   65 151 239 -122 4 -107 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   65 151 239 -122 2 -107 0 0   EBIT / employee   53 139 227 -134 -0 -107 0 0   Net earnings / employee   35 106 177 -106 -2 -111 0 0